United Guardian Inc (NASDAQ: UG)

United-Guardian, Inc. is a Delaware corporation that manufactures markets and develops specialty cosmetic personal care and sexual wellness ingredients as well as a line of healthcare products including pharmaceuticals and medical lubricants. The company traces its origins to United International Research Inc founded in 1942 by Dr Alfred R Globus and later merged with Guardian Chemical Corporation to become United-Guardian, Inc. All products except Renacidin are produced at its facility in Hauppauge New York while Renacidin is manufactured by an outside contract manufacturer. United-Guardian conducts research and development focused on creating new and unique hydrogel formulations for cosmetic personal care and sexual wellness applications using natural and environmentally friendly raw materials. The firm emphasizes product innovation to maintain its market position and to drive future growth in stable and growing markets such as personal care medical devices and healthcare.

United-Guardian generates revenue from the sale of its four product categories cosmetic ingredients medical lubricants pharmaceutical products and sexual wellness ingredients. In the fiscal year ended December 31 2025 cosmetic ingredients accounted for approximately twenty nine percent of total sales medical lubricants for twenty percent pharmaceutical products for fifty one percent and sexual wellness ingredients for negligible sales as the line was not yet commercialized. The company sells its cosmetic ingredients worldwide through a network of distributors including Ashland Specialty Ingredients Azelis Sederma Safic-Alcan and Brenntag Specialties who then resell the ingredients to manufacturers of personal care and cosmetic products. Medical lubricants are sold directly to manufacturers and marketers of finished medical products or to contract manufacturers employed by those companies. Pharmaceutical products are primarily distributed through three national full line drug wholesalers that supply pharmacies physicians hospitals long term care facilities and government agencies with a small portion sold directly to hospitals and pharmacies. Sexual wellness ingredients are intended for sale to manufacturers of intimate wipes personal moisturizers and related products once commercial production begins.

• no_segments_reported.

United-Guardian occupies a specialized niche in the specialty ingredients sector where competition is based on product performance price quality service and responsiveness to customer needs. Many competitors are larger firms with greater financial resources which gives them more operating and financial flexibility. The company differentiates itself through its proprietary hydrogel technology its focus on natural and sustainable formulations and its ability to develop products that fill unmet market needs. Its pharmaceutical product Renacidin benefits from being the only FDA approved drug for preventing and dissolving urethral catheter calcifications which limits direct competition in that segment. United-Guardian also leverages its long standing relationships with distributors and its reputation for high quality reliable supply to maintain its market standing.

The company serves cosmetic and personal care product manufacturers through its distributor network which includes Ashland Specialty Ingredients Azelis Sederma Safic-Alcan and Brenntag Specialties as well as other regional partners. Medical lubricants are supplied directly to manufacturers of medical devices such as catheter and surgical instrument producers and to contract manufacturers that produce those devices. Pharmaceutical products are distributed nationwide via three major full line drug wholesalers that in turn supply pharmacies physicians hospitals long term care facilities and government agencies with a small amount sold directly to healthcare providers. Once commercialized sexual wellness ingredients will be sold to manufacturers of intimate wipes personal moisturizers and related personal care products.